Drug Pipeline

Mitoxantrone Hydrochloride Liposome Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07486479 Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and… Acute Myeloid Leukemia (AML) Not Yet Recruiting
Phase 2
NCT07372352 Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL Peripheral T Cells Lymphoma (PTCL) Recruiting
Phase 1/2
NCT07093710 Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the… Peripheral T Cell Lymphoma Recruiting
NCT06594640 R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma Diffuse Large B-cell Lymphoma Recruiting
Sponsors Running Mitoxantrone Hydrochloride Liposome Trials
The First Affiliated Hospital of Soochow University (2) Institute of Hematology & Blood Diseases Hospital, China (1) Sun Yat-sen University (1)
Disease Areas
DLBCL (1) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Mitoxantrone Hydrochloride Liposome trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free